MedWatch·Industry news·Business & finance·1d agoWS Audiology moves closer to IPO as debt and interest costs fallWS Audiology is moving closer to an IPO as the company reduces its debt load and gearing ratio, long cited as a key prerequisite for a public listing.＋Save
MedWatch·Industry news·Business & finance·2d agoWS Audiology lags behind in key business area and goes all in on next wave of productsWS Audiology is underperforming in a key business segment and is banking on upcoming product launches, though meaningful financial impact is not expected until the next fiscal year.＋Save
MedWatch·Financial report·Business & finance·2d agoWS Audiology maintains guidance after positive Q2 growthWS Audiology maintained its full-year guidance following positive Q2 growth, though weak wholesale business performance—attributed to the timing of product launches—tempered overall results.＋Save
MedWatch·Industry news·Business & finance·3d agoGN partner move could reshape US hearing aid market: “A real game-changer"GN, both a supplier to and shareholder in NationsBenefits, may reshape the US discount hearing aid market as NationsBenefits is set to take over several hundred hearing centers.＋Save
MedWatch·Industry news·Business & finance·7d agoItalian owners evoke "mixed feelings" at GNGN's planned sale of its hearing aid unit to Italian retailer Amplifon is generating mixed staff sentiment, with management pledging investment in Denmark but questions remaining over the facility's identity.＋Save
MedWatch·Industry news·Business & finance·7d agoGN launches cost-cutting program: Aims to save USD 31.5 million per yearGN has announced a cost-cutting program targeting annual savings of USD 31.5 million, with the stated goal of improving the company's future earnings performance.＋Save
MedWatch·Financial report·Business & finance·7d agoDanske Bank sees promising outlook for Demant after strong Q1Danske Bank issued a positive outlook on Demant following strong Q1 results, highlighting the relaunch of the Oticon Zeal hearing aid as a notable development.＋Save
MedWatch·Financial report·Business & finance·8d agoDemant delivers strong start to the year on relaunch momentumDemant reports a strong start to fiscal 2026, driven by relaunch momentum, and maintains its full-year financial outlook.＋Save
MedWatch·Industry news·Business & finance·8d agoJyske Bank: Demant’s strong start points to high-end resultsJyske Bank analyst Janne Vincent Kjær says Demant is on track to meet 2026 expectations following a strong start to the fiscal year.＋Save
MedWatch·Industry news·Business & finance·8d agoDemant CEO teases new launches: "Our platform is very strong"Demant's CEO hints at upcoming product launches, crediting the Oticon Zeal's strong performance for lifting the broader portfolio in Q1 2026.＋Save
MedWatch·Financial report·Business & finance·8d agoAmplifon upgrades earnings guidance despite flat revenue – ready for GN mega-mergerAmplifon upgrades its full-year 2026 earnings guidance, projecting 3% organic growth and improved margins, while managing the ongoing integration of GN Hearing.＋Save
MedWatch·Financial report·Business & finance·8d agoDemant maintains guidance, sees lower-end outcome as "less likely"Demant maintains its organic growth guidance of 3–6% while characterizing a lower-end outcome as less likely, according to a financial update reported by MedWatch.＋Save
MedWatch·Financial report·Business & finance·10d agoDanske Bank sees potential focus on Demant’s miniature product launch and GN’s sale to Amplifon in interim reportDanske Bank analysts assessed Demant's need for new product launches to sustain sales growth and flagged GN's potential sale to Amplifon as key topics ahead of the companies' interim reports.＋Save
MedWatch·Industry news·Hearing aids·10d agoDemant launches Oticon Zeal through retail channels in the USDemant has launched the Oticon Zeal hearing aid through US retail channels, including inclusion in the Department of Veterans Affairs hearing aid contract.＋Save
MedWatch·Industry news·Business & finance·10d agoEQT has selected banks for a potential IPO of WS AudiologyPrivate equity firm EQT has selected banks for a potential IPO of WS Audiology, though sources indicate no final decision has been made.＋Save
